- Home
- CHRO vs AQB Comparison
CHRO vs AQB Comparison
Compare CHRO & AQB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRO
- AQB
- Stock Information
- Founded
- CHRO 2002
- AQB 1991
- Country
- CHRO United States
- AQB United States
- Employees
- CHRO N/A
- AQB N/A
- Industry
- CHRO
- AQB
- Sector
- CHRO
- AQB
- Exchange
- CHRO Nasdaq
- AQB Nasdaq
- Market Cap
- CHRO 4.2M
- AQB 3.4M
- IPO Year
- CHRO 2024
- AQB N/A
- Fundamental
- Price
- CHRO $0.60
- AQB $0.59
- Analyst Decision
- CHRO Strong Buy
- AQB Hold
- Analyst Count
- CHRO 1
- AQB 2
- Target Price
- CHRO N/A
- AQB N/A
- AVG Volume (30 Days)
- CHRO 121.3K
- AQB 112.4K
- Earning Date
- CHRO 11-13-2024
- AQB 11-05-2024
- Dividend Yield
- CHRO N/A
- AQB N/A
- EPS Growth
- CHRO N/A
- AQB N/A
- EPS
- CHRO N/A
- AQB N/A
- Revenue
- CHRO N/A
- AQB $1,258,512.00
- Revenue This Year
- CHRO N/A
- AQB N/A
- Revenue Next Year
- CHRO N/A
- AQB $57.38
- P/E Ratio
- CHRO N/A
- AQB N/A
- Revenue Growth
- CHRO N/A
- AQB N/A
- 52 Week Low
- CHRO $0.45
- AQB $0.55
- 52 Week High
- CHRO $6.00
- AQB $3.00
- Technical
- Relative Strength Index (RSI)
- CHRO 48.49
- AQB 24.74
- Support Level
- CHRO $0.55
- AQB $0.55
- Resistance Level
- CHRO $0.71
- AQB $0.97
- Average True Range (ATR)
- CHRO 0.10
- AQB 0.08
- MACD
- CHRO -0.00
- AQB -0.03
- Stochastic Oscillator
- CHRO 23.98
- AQB 4.52
About CHRO Chromocell Therapeutics Corporation
Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.
About AQB AquaBounty Technologies Inc.
AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.